Suchergebnisse - "Van Driest, Sara L"

PubPharm (177)

91

Induced Pluripotent Stem Cells : From the Bedside to the Bench, and Hopefully Back Again

enthalten in: Clinical Pharmacology & Therapeutics | 2020

von Van Driest, S. | Graaf, P.

92

CYP2C19 Phenotype and Risk of Proton Pump Inhibitor-Associated Infections

enthalten in: Pediatrics | 2019

von Bernal, C. | Aka, I. | Carroll, R. | +5

CommentIn: Pediatrics. 2019 Dec;144(6):. - PMID 31699830

93

Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing

enthalten in: Genetics in medicine : official journal of the American College of Medical Genetics | 2019

von Cavallari, L. | Van Driest, S. | Prows, C. | +25

94

Hypertension is a modifiable risk factor for osteonecrosis in acute lymphoblastic leukemia

enthalten in: Blood | 2019

von Janke, L. | Van Driest, S. | Portera, M. | +10

95

Pharmacogenomics

enthalten in: Lancet (London, England) | 2019

von Roden, D. | McLeod, H. | Relling, M. | +4

96

CYP2C9*2 is associated with indomethacin treatment failure for patent ductus arteriosus

enthalten in: Pharmacogenomics | 2019

von Rooney, S. | Shelton, E. | Aka, I. | +8

97

Real-World Data for Pediatric Pharmacometrics : Can We Upcycle Clinical Data for Research Use?

enthalten in: Clinical pharmacology and therapeutics | 2019

von Van Driest, S. | Choi, L.

98

Reply to Wasko et al

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2019

von Dare, R. | Van Driest, S. | Talbot, T.

CommentOn: Clin Infect Dis. 2018 Oct 15;67(9):1356-1363. - PMID 29668884

99

Incidence of Nephrotoxicity Among Pediatric Patients Receiving Vancomycin With Either Piperacillin-Tazobactam or Cefepime : A Cohort Study

enthalten in: Journal of the Pediatric Infectious Diseases Society | 2019

von Cook, K. | Gillon, J. | Grisso, A. | +4

100

Adverse Events Associated with Risperidone Use in Pediatric Patients : A Retrospective Biobank Study

enthalten in: Drugs - real world outcomes | 2019

von Oshikoya, K. | Carroll, R. | Aka, I. | +2